|
|
||||||||
Clinical Chemistry, Vol 35, 2311-2312, Copyright © 1989 by American Association for Clinical Chemistry
JE Buttery, BR Chamberlain and CG Beng
Department of Clinical Chemistry, Queen Elizabeth Hospital, Woodville, South Australia.
In this screening method for urinary porphobilinogen (PBG), urine is added to Dowex 2 resin under alkaline conditions in a test tube and mixed. The supernate is removed and the adsorbed PBG is eluted with acid and reacted with Ehrlich's reagent. We compared results with those by the Watson-Schwartz screening method, using urine samples from normal people with and without added PBG. At a PBG concentration of about five times the upper limit of normal, the resin method gave a sensitivity of 100%; the Watson-Schwartz method gave a sensitivity of 51%. At lower PBG concentrations of just over and twice the upper limit of normal, the sensitivity by the resin method was respectively 97% and 100%. With normal urine samples, the resin method gave negative results for all samples (100% specificity) and the Watson-Schwartz had 95% specificity. Our data indicate that the resin method is sensitive, specific, and reliable and is superior to the Watson-Schwartz method.
The following articles in journals at HighWire Press have cited this article:
![]() |
A. Schreiber, S. Elitok, and R. Kettritz Solving electrolyte disturbances with the Ehrlich reagent Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1217 - 1219. [Full Text] [PDF] |
||||
![]() |
A. Gorchein Testing for Porphobilinogen in Urine Clin. Chem., March 1, 2002; 48(3): 564 - 566. [Full Text] [PDF] |
||||
![]() |
C. A. Pierach Porphyria Conundrum Clin. Chem., July 1, 1999; 45(7): 932 - 933. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |